Spark Investment Management LLC Zynerba Pharmaceuticals, Inc. Transaction History

Spark Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$5.4 - $15.5 $130,140 - $373,550	-24,100 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$3.6 - $6.22 $273,240 - $472,098	-75,900 Reduced 75.9%	24,100 $130,000
Q4 2018 Feb 12, 2019	BUY	$2.89 - $7.91 $289,000 - $791,000	100,000 New	100,000 $297,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.